News
Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.
United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...
A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...
3d
Zacks.com on MSNMerck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook CutMRK posts better-than-expected first-quarter results but trims its 2025 EPS outlook due to anticipated one-time charges.
Merck (MRK) stock trades flat as the company lowers earnings outlook amid tariff impact, even as its Q1 2025 results beat ...
The vaccine, known as Gardasil, has been given to millions of ... Currently, CDC recommendations already suggest adolescents aged 9 to 14 get two doses. Three doses are recommended for teens ...
Merck said today its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results